Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Physiological, Molecular and Biotechnological Interventions
Researchers investigate BPC-157 for its mechanisms involving nitric oxide pathway modulation, VEGFR2-mediated angiogenesis, and growth factor transactivation
[PMID: 361374] PubMed record related to this compound for laboratory literature review
To exclude potential kinetic differences in the ability of DA to recruit -arrestin2 versus G i1 , time-course experiments showed that receptor stimulation by DA does not result in the recruitment of -arrestin2 at any of the time points tested (data not shown)
Preclinical studies show GHK-Cu is active at very low doses in animals (approximately 0.5 mcg/kg in rodent models) [15] , while clinical practice employs milligram-range dosing in humans to achieve systemic effects [5] [6]
